AstraZeneca reports 6% rise in Q2 2024 net profit to $1.92bn
The British pharmaceutical company reported total revenues of $12.93bn for Q2 2024, a 13% increase compared to $11.41bn for the same quarter in 2023, and a 2% rise compared to...
![](https://www.worldpharmaceuticals.net/wp-content/uploads/sites/12/2024/07/New-Project-141-1024x576.webp)
A leading resource for the Pharmaceutical industry since 2002
The British pharmaceutical company reported total revenues of $12.93bn for Q2 2024, a 13% increase compared to $11.41bn for the same quarter in 2023, and a 2% rise compared to...
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry